Tris(2,3-dibromopropyl) phosphate.
D000818:Animals; D002273:Carcinogens; D005260:Female; D005411:Flame Retardants; D006801:Humans; D006842:Hydrocarbons, Brominated / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D006967:Hypersensitivity; D008297:Male; D051379:Mice; D009154:Mutation / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010755:Organophosphates; D009943:Organophosphorus Compounds / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats; D012306:Risk; D012486:Salmonella typhimurium / Q000187:drug effects; D012867:Skin / Q000187:drug effects
D002273:Carcinogens; D005411:Flame Retardants; D006842:Hydrocarbons, Brominated; D010755:Organophosphates; D009943:Organophosphorus Compounds; C012085:tris(2,3-dibromopropyl)phosphate